A German outbreak of haemolytic uraemic syndrome
LANCET (2011)
期刊
LANCET
卷 378, 期 9796, 页码 1057-1058出版社
ELSEVIER SCIENCE INC
关键词
作者
我是这篇论文的作者
推荐
Haemolytic uraemic syndrome
Mini Michael, Arvind Bagga, Sarah E. Sartain, Richard J. H. Smith
LANCET (2022)
Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
Yahiya Y. Syed
DRUGS (2021)
Interventions for atypical haemolytic uraemic syndrome
Dan Pugh, Eoin D. O'Sullivan, Fiona Ai Duthie, Philip Masson, David Kavanagh
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
Irene Gomez Delgado, Fernando Corvillo, Pilar Nozal, Emilia Arjona, Alvaro Madrid, Marta Melgosa, Juan Bravo, Agnes Szilagyi, Dorottya Csuka, Nora Veszeli, Zoltan Prohaszka, Pilar Sanchez-Corral
FRONTIERS IN IMMUNOLOGY (2021)
Outcome of atypical haemolytic uraemic syndrome relapse after eculizumab withdrawal
Caroline Duineveld, Romy Bouwmeester, Joost W. van der Heijden, Stefan P. Berger, Nicole C. A. J. van de Kar, Jack F. M. Wetzels
CLINICAL KIDNEY JOURNAL (2021)
Haemolytic uraemic syndrome associated with pancreatids: report of four cases and review of the literature
Justo Sandino-Perez, Eduardo Gutierrez, Fernando Caravaca-Fontan, Enrique Morales, Lucia Aubert-Girbal, Ramon Delgado-Lillo, Manuel Praga
CLINICAL KIDNEY JOURNAL (2021)
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome syndrome
Aamer Imdad, Samuel P. Mackoff, David M. Urciuoli, Tamkeenat Syed, Emily E. Tanner-Smith, Dongmei Huang, Oscar G. Gomez-Duarte
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study
Jose Portoles, Ana Huerta, Emilia Arjona, Eva Gavela, Marisa Aguera, Carlos Jimenez, Teresa Cavero, Domingo Marrero, Santiago Rodriguez de Cordoba, Fritz Diekmann
CLINICAL KIDNEY JOURNAL (2021)
Incidence and cost of haemolytic uraemic syndrome in urban China: a national population-based analysis
Jingnan Feng, Ke Xu, Xinmiao Shi, Lu Xu, Lili Liu, Fang Wang, Xuhui Zhong, Guozhen Liu, Jinxi Wang, Pei Gao, Jie Ding, Shengfeng Wang, Siyan Zhan
BMC NEPHROLOGY (2022)
Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan
Shuichi Ito, Hiroshi Hataya, Akira Ashida, Riku Hamada, Tomoaki Ishikawa, Yumiko Ishikawa, Akihiko Shimono, Takao Konomoto, Tomoki Miyazawa, Masao Ogura, Kazuki Tanaka, Shoji Kagami
NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)
Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes
Gema Ariceta, Fadi Fakhouri, Lisa Sartz, Benjamin Miller, Vasilis Nikolaou, David Cohen, Andrew M. Siedlecki, Gianluigi Ardissino
CLINICAL KIDNEY JOURNAL (2021)
Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective
Mendy ter Avest, Romy N. Bouwmeester, Caroline Duineveld, Kioa L. Wijnsma, Elena B. Volokhina, Lambertus P. W. J. van den Heuvel, David M. Burger, Jack F. M. Wetzels, Nicole C. A. J. van de Kar, Rob ter Heine
NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)
Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study
Lisa Byrne, Amy Douglas, Naomi Launders, Gauri Godbole, Richard Lynn, Carol Inward, Claire Jenkins
EPIDEMIOLOGY AND INFECTION (2023)
A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report
Muneera Alabdulqader, Khalid Alfakeeh
BMC NEPHROLOGY (2021)
Low factor H-related 5 levels contribute to infection-triggered haemolytic uraemic syndrome and membranoproliferative glomerulonephritis
Irene Gomez Delgado, Josue Gutierrez-Tenorio, Gloria M. Fraga Rodriguez, Teresa Cavero, Emilia Arjona, Pilar Sanchez-Corral
CLINICAL KIDNEY JOURNAL (2021)
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial
Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, Ilian Petrov Iliev, Flavio Gaspari, Silvia Ferrari, Nadia Stucchi, Antonio Bossi, Roberto Trevisan, Giuseppe Remuzzi, Aneliya Parvanova
ACTA DIABETOLOGICA (2022)
Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF-A/caveolin-1/PV-1 signaling pathway
Monica Locatelli, Carlamaria Zoja, Sara Conti, Domenico Cerullo, Daniela Corna, Daniela Rottoli, Cristina Zanchi, Susanna Tomasoni, Giuseppe Remuzzi, Ariela Benigni
JOURNAL OF PATHOLOGY (2022)
Glomerular hyperfiltration
Monica Cortinovis, Norberto Perico, Piero Ruggenenti, Andrea Remuzzi, Giuseppe Remuzzi
NATURE REVIEWS NEPHROLOGY (2022)
Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 Activation
Anna Pezzotta, Luca Perico, Marina Morigi, Daniela Corna, Monica Locatelli, Carlamaria Zoja, Ariela Benigni, Giuseppe Remuzzi, Barbara Imberti
CELLS (2022)
Immunological reviews: The alternative pathway or amplification loop of complement
Erica Daina, Monica Cortinovis, Giuseppe Remuzzi
IMMUNOLOGICAL REVIEWS (2023)
MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and preserved kidney function: A cross-sectional study
Aneliya Parvanova, Manuela Abbate, Aina Maria Yanez, Miquel Bennasar-Veny, Angel Arturo Lopez-Gonzalez, Jose Ignacio Ramirez-Manent, Ilian Petrov Iliev, Sergio Fresneda, Maria Arias-Fernandez, Giuseppe Remuzzi, Piero Ruggenenti
DIABETES RESEARCH AND CLINICAL PRACTICE (2023)
Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine
Piera Trionfini, Elena Romano, Marco Varinelli, Lorena Longaretti, Paola Rizzo, Roberta Giampietro, Annalina Caroli, Sistiana Aiello, Marta Todeschini, Federica Casiraghi, Giuseppe Remuzzi, Ariela Benigni, Susanna Tomasoni
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
Norberto Perico, Giuseppe Remuzzi, Matthew D. Griffin, Paul Cockwell, Alexander P. Maxwell, Federica Casiraghi, Nadia Rubis, Tobia Peracchi, Alessandro Villa, Marta Todeschini, Fabiola Carrara, Bernadette A. Magee, Piero L. Ruggenenti, Stefano Rota, Laura Cappelletti, Veronica Mcinerney, Tomas P. Griffin, Md Nahidul Islam, Martino Introna, Olga Pedrini, Josee Golay, Andrew A. Finnerty, Jon Smythe, Willem E. Fibbe, Stephen J. Elliman, Timothy O'Brien, NEPHSTROM Trial Consortium
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention
Damiano Baldassarre, Licia Iacoviello, Roberta Baetta, Maria Carla Roncaglioni, Gianluigi Condorelli, Giuseppe Remuzzi, Gianfranco Gensini, Luigi Frati, Walter Ricciardi, Pier Giulio Conaldi, Antonio Uccelli, Fabio Blandini, Silvano Bosari, Giovanni Scambia, Massimo Fini, Antonio Di Malta, Mauro Amato, Fabrizio Veglia, Alice Bonomi, Catherine Klersy, Francesca Colazzo, Martino Pengo, Francesca Gorini, Luciana Auteri, Giuseppe Ferrante, Marta Baviera, Giuseppe Ambrosio, Alberico Catapano, Alessandro Gialluisi, Alexis Elias Malavazos, Serenella Castelvecchio, Massimiliano Marco Corsi-Romanelli, Rosanna Cardani, Maria Teresa La Rovere, Valentina Agnese, Bianca Pane, Daniele Prati, Laura Spinardi, Giovanna Liuzzo, Eloisa Arbustini, Maurizio Volterrani, Marco Visconti, Jose Pablo Werba, Stefano Genovese, Grzegorz Bilo, Cecilia Invitti, Anna Di Blasio, Carolina Lombardi, Andrea Faini, Debora Rosa, Luisa Ojeda-Fernandez, Andreana Foresta, Amalia De Curtis, Augusto Di Castelnuovo, Simonetta Scalvini, Antonia Pierobon, Alessandra Gorini, Luca Valenti, Livio Luzi, Annarosa Racca, Manuela Bandi, Elena Tremoli, Lorenzo Menicanti, Gianfranco Parati, Giulio Pompilio
BMJ OPEN (2023)
The ethics of peer review process
Giuseppe Remuzzi
UPDATES IN SURGERY (2023)
Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs
Angelo M. Lavecchia, Polyxeni Mantzouratou, Domenico Cerullo, Monica Locatelli, Sara Conti, Matteo Tironi, Fabio Sangalli, Daniela Corna, Carlamaria Zoja, Giuseppe Remuzzi, Christodoulos Xinaris
ISCIENCE (2023)
Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD
Anna Caroli, Giulia Villa, Paolo Brambilla, Matias Trillini, Kanishka Sharma, Sandro Sironi, Giuseppe Remuzzi, Norberto Perico, Andrea Remuzzi
EUROPEAN RADIOLOGY (2023)
Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic Syndrome
Federica Casiraghi, Marta Todeschini, Manuel Alfredo Podesta, Marilena Mister, Barbara Ruggiero, Matias Trillini, Camillo Carrara, Olimpia Diadei, Alessandro Villa, Ariela Benigni, Giuseppe Remuzzi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection
Monica Locatelli, Daniela Rottoli, Rayan Mahmoud, Mauro Abbate, Daniela Corna, Domenico Cerullo, Susanna Tomasoni, Giuseppe Remuzzi, Carlamaria Zoja, Ariela Benigni, Daniela Macconi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Primary care in a National Health Service: time for radical reform
Livio Garattini, Michela Bozzetto, Giuseppe Remuzzi, Nick Freemantle, Alessandro Nobili
FAMILY PRACTICE (2022)